GSA Capital Partners’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,257
| Closed | -$41K | – | 2096 |
|
|
2024
Q1 | $41K | Sell |
1,257
-4,998
| -80% | -$163K | ﹤0.01% | 1541 |
|
|
2023
Q4 | $167K | Buy |
+6,255
| New | +$167K | 0.01% | 1357 |
|
|
2023
Q3 | – | Sell |
-2,269
| Closed | -$231K | – | 1989 |
|
|
2023
Q2 | $231K | Buy |
2,269
+1,643
| +262% | +$167K | 0.02% | 1191 |
|
|
2023
Q1 | $111K | Buy |
+626
| New | +$111K | 0.01% | 1347 |
|
|
2022
Q3 | – | Sell |
-3,348
| Closed | -$1.1M | – | 1933 |
|
|
2022
Q2 | $1.1M | Buy |
3,348
+2,999
| +859% | +$985K | 0.17% | 107 |
|
|
2022
Q1 | $153K | Buy |
+349
| New | +$153K | 0.02% | 1230 |
|
|
2019
Q4 | – | Sell |
-474
| Closed | -$312K | – | 1780 |
|
|
2019
Q3 | $312K | Buy |
+474
| New | +$312K | 0.04% | 863 |
|
|
2016
Q4 | – | Sell |
-1,089
| Closed | -$327K | – | 2002 |
|
|
2016
Q3 | $327K | Buy |
+1,089
| New | +$327K | 0.02% | 1311 |
|
|
2016
Q2 | – | Sell |
-1,556
| Closed | -$348K | – | 1954 |
|
|
2016
Q1 | $348K | Sell |
1,556
-974
| -38% | -$218K | 0.02% | 1227 |
|
|
2015
Q4 | $1.54M | Buy |
2,530
+577
| +30% | +$350K | 0.08% | 399 |
|
|
2015
Q3 | $1.01M | Buy |
+1,953
| New | +$1.01M | 0.05% | 620 |
|
|
2015
Q1 | – | Sell |
-294
| Closed | -$106K | – | 2238 |
|
|
2014
Q4 | $106K | Sell |
294
-256
| -47% | -$92.3K | 0.01% | 1583 |
|
|
2014
Q3 | $166K | Buy |
+550
| New | +$166K | 0.01% | 1559 |
|